CRISPR Gene-Editing Offered To British Blood Disorder Patients 🧬

News & Articles
1

  1. NHS Introduces Gene-Editing
    The NHS is offering a revolutionary CRISPR therapy for beta thalassaemia patients.

  2. Potential Cure
    The therapy could spare patients from lifelong blood transfusions by correcting the genetic defect.

  3. Impact on Patients
    Beta thalassaemia causes severe fatigue and shortens life expectancy, making this a significant breakthrough.

Read more at: BBC